Skip to main content

EU s Newmood Project Launched at HUGO

NEW YORK, April 7 (GenomeWeb News) –  The European Union’s Newmood project launched this week at the Human Genome meeting in Berlin, Germany, according to news reports.

Newmood is a five-year project funded under the EC’s 6th Framework with  €7.3 million ($8.3M US) bringing together 13 laboratories over 10 countries to investigate the genetics of depression with the aim of developing new drug targets and to aid in the diagnosis.

According to a report published online today by Nature , researchers in the project will build an array of 800 genes that may be related to depression, including those affecting metabolism, growth and cell communication. The chip will detect which genes are active in healthy and depressed animals and humans.

Bill Deakin of the Neuroscience and Psychiatry unit of Manchester University (UK) is the project coordinator.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.